Kim K, Jung S, Kim M, Park S, Yang H-J, Lee E Global trends in the proportion of Macrolide-Resistant < i > Mycoplasma p neumoniae infections. JAMA Netw Open, 5(7):e2220949. https://doi.org/10.1001/jamanetworkopen.2022.20949

Ding G, Zhang X, Vinturache A, van Rossum AMC, Yin Y, Zhang Y (2024) Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Eur J Pediatr 183(7):3001–3011. https://doi.org/10.1007/s00431-024-05519-1

Article  PubMed  Google Scholar 

Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A Macrolide-Resistant < i > Mycoplasma pneumoniae infections in Childre n, ohio, USA. Emerg Infect Dis, 27(6):1588–1597https://doi.org/10.3201/eid2706.203206

Oishi T, Ouchi K Recent trends in the epidemiology, diagnosis, and treatment of Macroli de-Resistant Mycoplasma pneumoniae. JCM, 11(7):1782https://doi.org/10.3390/jcm11071782

Lee JK, Lee T, Kim Y-J, Kim DR, Shin A, Kang HM, Kim YJ, Kim DH, Eun BW, Choe YJ et al Clinical manifestations, macrolide resistance, and treatment utilizati on trends of Mycoplasma pneumoniae pneumonia in children and Adolescen Ts in South Korea. Microorganisms, 12(9):1806https://doi.org/10.3390/microorganisms12091806

Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E (2022) Global trends in the proportion of Macrolide-Resistant Mycoplasma pneumoniae infections: A systematic review and Meta-analysis. JAMA Netw Open 5(7):e2220949. https://doi.org/10.1001/jamanetworkopen.2022.20949

Article  PubMed  PubMed Central  Google Scholar 

Leng M, Yang J, Liu X (2024) Macrolide-resistant mycoplasma pneumoniae infection in children observed during a period of high incidence in Henan, China. Heliyon 10(13):e33697https://doi.org/10.1016/j.heliyon.2024.e33697

Contes KM, Liu BM (2025) Epidemiology, clinical significance, and diagnosis of respiratory viruses and their Co-Infections in the Post-COVID era. Pathogens 14(3). https://doi.org/10.3390/pathogens14030262

Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM (2016) Infection with and carriage of Mycoplasma pneumoniae in children. Front Microbiol 7:329. https://doi.org/10.3389/fmicb.2016.00329

Article  PubMed  PubMed Central  Google Scholar 

Jiang Y, Dou H, Xu B, Xu B, Zhou W, Wang H, Ge L, Hu Y, Han X, Qin X et al (2024) Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019. Epidemiol Infect 152e75. https://doi.org/10.1017/s0950268824000323

Xu M, Li Y, Shi Y, Liu H, Tong X, Ma L, Gao J, Du Q, Du H, Liu D et al (2024) Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, wuhan, 2020–2022. BMC Microbiol 24(1):23. https://doi.org/10.1186/s12866-024-03180-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Jia X, Gao Y, Ren X, Du B, Zhao H, Feng Y, Xue G, Cui J, Gan L et al (2024) Increased macrolide resistance rate of Mycoplasma pneumoniae correlated with epidemic in beijing, China in 2023. Front Microbiol 151449511. https://doi.org/10.3389/fmicb.2024.1449511

Xu L, Wang P, Wang Y, Liu B, Xu X, Yang Q, Gao C, Sun H, Xu Y, Xu Q et al (2024) Epidemiological, clinical, and genotypic characteristics of pediatric Mycoplasma pneumoniae infections: an 8-year survey in suzhou, China in the pre- and post-COVID-19 eras. Front Microbiol 15:1483152. https://doi.org/10.3389/fmicb.2024.1483152

Article  PubMed  PubMed Central  Google Scholar 

Dekyi XY, Wang X, Feng S, Wang Y, Liao L, Wang S, Deng Y, Zheng J, Zhao D (2024) Predominance of A2063G mutant strains in the Mycoplasma pneumoniae epidemic in children: A clinical and epidemiological study in 2023 in wuhan, China. Int J Infect Dis 145107074. https://doi.org/10.1016/j.ijid.2024.107074

Yan M, Tao R, Li S, Xiong J, Xiang J (2024) Clinical characteristics and logistic regression analysis of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Eur J Clin Microbiol Infect Dis 43(9):1825–1835. https://doi.org/10.1007/s10096-024-04902-y

Article  CAS  PubMed  Google Scholar 

Zhao Shunying QS, Chen Z, Hengmiao G, Hanmin L, Hailin Z, Jinrong L (2024) Guidelines for diagnosis and treatment of Mycoplasma Pneumonae pneumonia in children (2023 Edition). Electron J Emerg Infect Dis. https://doi.org/10.19871/j.cnki.xfcrbzz.2024.01.015

Article  Google Scholar 

Xin N (2019) Diagnosis and treatment guidelines for children’s Community-Acquired pneumonia (2019 edition). Clin Educ Gen Pract 17(09):771–777. https://doi.org/10.13558/j.cnki.issn1672-3686.2019.09.002

Article  Google Scholar 

Lee JK, Choi YY, Sohn YJ, Kim KM, Kim YK, Han MS, Park JY, Cho EY, Choi JH, Choi EH (2022) Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South korea, 2019–2020. J Microbiol Immunol Infect 55(5):910–916. https://doi.org/10.1016/j.jmii.2021.07.011

Article  CAS  PubMed  Google Scholar 

Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, Saito A, Kondo E, Teranishi H, Wakabayashi T et al (2013) Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother 57(8):4046–4049. https://doi.org/10.1128/aac.00663-13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao F, Liu J, Shi W, Huang F, Liu L, Zhao S, Zhang J (2019) Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in beijing, china, from 2014 to 2016. Antimicrob Resist Infect Control 8:18. https://doi.org/10.1186/s13756-019-0469-7

Article  PubMed  PubMed Central  Google Scholar 

Zhao F, Liu G, Wu J, Cao B, Tao X, He L, Meng F, Zhu L, Lv M, Yin Y et al (2013) Surveillance of macrolide-resistant Mycoplasma pneumoniae in beijing, china, from 2008 to 2012. Antimicrob Agents Chemother 57(3):1521–1523. https://doi.org/10.1128/aac.02060-12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao B, Qu JX, Yin YD, Eldere JV (2017) Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J 11(4):419–429. https://doi.org/10.1111/crj.12379

Article  CAS  PubMed  Google Scholar 

Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP (2017) Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev 30(3):747–809. https://doi.org/10.1128/cmr.00114-16

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loconsole D, De Robertis AL, Sallustio A, Centrone F, Morcavallo C, Campanella S, Accogli M, Chironna M (2021) Update on the epidemiology of Macrolide-Resistant Mycoplasma pneumoniae in europe: A systematic review. Infect Dis Rep 13(3):811–820. https://doi.org/10.3390/idr13030073

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Li M, Luo M, Luo Q, Kang L, Xie H, Wang Y, Yu X, Li A, Dong M et al (2022) Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infect 11(1):1508–1517. https://doi.org/10.1080/22221751.2022.2078228

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du H, Li J, Li X, Zhao J, Lu W, Zhang Q, Liu W, Luo X, Lu Q, Hu S et al (2024) Impact of the COVID-19 pandemic on epidemiological and clinical characteristics of Mycoplasma pneumoniae pneumonia in children: a multicenter study from hubei, China. Front Pediatr 12:1388132. https://doi.org/10.3389/fped.2024.1388132

Article  PubMed  PubMed Central  Google Scholar 

Mao BB, Chen DN, Lu WW, Liu CY, Li ZL, Chen CS, Qiu HY, Liu WY (2024) [Epidemic characteristics of mycoplasma pneumoniae infection and drug-resistant gene mutations in hospitalized children aged 0–17 in Ningbo City from 2019 to 2023]. Zhonghua Yu Fang Yi Xue Za Zhi 58(7):1035–1040. https://doi.org/10.3760/cma.j.cn112150-20231123-00368

Article  CAS  PubMed  Google Scholar 

Zhu X, Liu P, Yu H, Wang L, Zhong H, Xu M, Lu L, Jia R, Su L, Cao L et al (2024) An outbreak of Mycoplasma pneumoniae in children after the COVID-19 pandemic, shanghai, china, 2023. Front Microbiol 15:1427702. https://doi.org/10.3389/fmicb.2024.1427702

Article  PubMed  PubMed Central  Google Scholar 

Liu BM, Yao Q, Cruz-Cosme R, Yarbrough C, Draper K, Suslovic W, Muhammad I, Contes KM, Hillyard DR, Teng S et al (2025) Genetic conservation and diversity of SARS-CoV-2 envelope gene across variants of concern. J Med Virol 97(1):e70136. https://doi.org/10.1002/jmv.70136

Article  CAS  PubMed  Google Scholar 

Cheng J, Liu Y, Zhang G, Tan L, Luo Z Azithromycin effectiveness in children with mutated Mycoplasma Pneumon Iae pneumonia. IDR, 17:2933–2942https://doi.org/10.2147/idr.s466994

Zhang Y-x, Li Y, Wang Y, Ren Y-f, Yang Y, Qi J, Yang H, Liang X, Zhang R -f: prospective cohort study on the clinical significance of interferon-γ, D-dimer, LDH, and CRP tests in children with severe mycoplasma Pneumo Nia. Medicine, 103(41):e39665. https://doi.org/10.1097/md.0000000000039665

Huang W, Xu X, Zhao W, Cheng Q (2022) Refractory Mycoplasma pneumonia in children: A systematic review and Meta-analysis of laboratory features and predictors. J Immunol Res 2022(9227838). https://doi.org/10.1155/2022/9227838

Wang C, Wen J, Yan Z, Zhou Y, Gong Z, Luo Y, Li Z, Zheng K, Zhang H, Ding N et al Suppressing neutrophil Itaconate production attenuates Mycoplasma Pneu moniae Pneumonia. PLoS Pathog, 20(11):e1012614https://doi.org/10.1371/journal.ppat.1012614

Li Y-t, Zhang J, Wang M-z, Ma Y-M, Zhi K, Dai F-L, Li S-j Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity. Ital J Pediatr, 49(1). https://doi.org/10.1186/s13052-023-01545-1

Zheng Y, Hua L, Zhao Q, Li M, Huang M, Zhou Y, Wang Y, Chen Z, Zhang Y (2021) The level of D-Dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children. Front Cell Infect Microbiol 11:687391. https://doi.org/10.3389/fcimb.2021.687391

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu BM, Hill HR (2020) Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: A review. J Interferon Cytokine Res 40(12):549–554. https://doi.org/10.1089/jir.2020.0210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lakshmanan K, Liu BM (2025) Impact of Point-of-Care testing on diagnosis, treatment, and surveillance of Vaccine-Preventable viral infections. Diagnostics (Basel) 15(2).